Knockdown of PRC1 using siRNA significantly suppresses the growth of breast and bladder cancer cells, indicating its crucial role in proliferation of cancer cells, and also suggesting PRC1 is a promising molecular target for human cancer treatment 12, 13. This evidence concerns the gene PRC1 and urinary bladder cancer.